Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Pediatr Blood Cancer. 2014 Feb;61(2):276-80. doi: 10.1002/pbc.24685. Epub 2013 Aug 23.
Healthcare associated mold infections (HAEMI) increase morbidity and mortality in children with leukemia. Excavation adjacent to Children's Medical Center Dallas (CMCD) April 2006-February 2007 provided an opportunity to determine if excavation adjacent to a hospital building is associated with increased risk of developing HAEMI in children receiving intensive chemotherapy for acute leukemia.
Children who began receiving intensive chemotherapy for acute leukemia at CMCD from 2004 to 2008 were identified (n = 275). Exposures to the CMCD campus during intensive chemotherapy and duration of neutropenia per exposure were recorded. Proven, probable, or possible invasive fungal disease (IFD) was classified using EORTC/MSG guidelines. Institutional guidelines categorized mold infections as definite or possible HAEMI. A bivariate time-to-event model compared the association of excavation with HAEMI and yeast infections, controlling for neutropenia.
There were 7,454 CMCD exposures, 1,007 (13.5%) during excavation. Of 50 cases of IFD, 31 were HAEMI. By time-to-event analysis exposure to the CMCD campus during the excavation period was significantly associated with HAEMI (HR = 2.8, P = 0.01) but not yeast infections (HR = 0.75, P = 0.75). Neutropenia was significantly associated with both HAEMI and yeast infections (P < 0.001). Voriconazole prophylaxis did not prevent HAEMI in 42% of the 14 patients with AML who had been receiving this agent.
This study is the first to demonstrate an association between exposure to hospital construction that includes excavation and HAEMI in pediatric oncology patients. Since neutropenic patients need protection from aerosolized fungal spores during visits to expanding medical centers, preventive strategies with adherence monitoring need additional study.
医疗保健相关霉菌感染(HAEMI)会增加白血病患儿的发病率和死亡率。2006 年 4 月至 2007 年 2 月,达拉斯儿童医疗中心(CMCD)附近的挖掘工作为我们提供了一个机会,以确定在紧邻医院建筑的地方进行挖掘是否会增加接受强化化疗治疗急性白血病的儿童患 HAEMI 的风险。
我们确定了 2004 年至 2008 年期间在 CMCD 接受强化化疗治疗急性白血病的儿童(n=275)。记录了他们在强化化疗期间暴露于 CMCD 校园的情况以及每次暴露时中性粒细胞减少的持续时间。采用 EORTC/MSG 指南对已证实、可能或疑似侵袭性真菌病(IFD)进行分类。根据机构指南,霉菌感染被归类为明确或可能的 HAEMI。采用双变量时间事件模型比较了挖掘与 HAEMI 和酵母感染的相关性,同时控制了中性粒细胞减少的因素。
共发生了 7454 次 CMCD 暴露,其中 1007 次(13.5%)发生在挖掘期间。50 例 IFD 中有 31 例为 HAEMI。通过时间事件分析,在挖掘期间暴露于 CMCD 校园与 HAEMI 显著相关(HR=2.8,P=0.01),但与酵母感染无关(HR=0.75,P=0.75)。中性粒细胞减少与 HAEMI 和酵母感染均显著相关(P<0.001)。在接受伏立康唑预防治疗的 14 例 AML 患者中,有 42%的患者发生了 HAEMI。
这项研究首次证明了在儿科肿瘤患者中,暴露于包含挖掘的医院建筑与 HAEMI 之间存在关联。由于接受强化化疗治疗的中性粒细胞减少患者在前往不断扩大的医疗中心就诊期间需要防止吸入真菌孢子,因此需要对具有依从性监测的预防策略进行进一步研究。